Analysis of HCV DAA resistance mutations in HIV and HTLV-1 superinfection cases

Analysis of HCV DAA resistance mutations in HIV and HTLV-1 superinfection cases - Analysis of HCV DAA resistance mutations in HIV and HTLV-1 superinfection cases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017059

Enrollment

Registered

2015-04-13

Start date

2015-04-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients HCV RNA is positive, and the HIV antibody or HTLV-1 antibody-positive,

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients was admitted to our hospital from January 2008 to December 2014 -Patients HCV RNA is positive, and the HIV antibody or HTLV-1 antibody-positive -Cases save serum amount (500Micro milliliter) is stored

Exclusion criteria

Exclusion criteria: -Patients already that against HCV, interventions such as IFN treatment has been carried out -HCV RNA is a viral load low value is also positive, nucleotide sequence analysis is difficult cases

Design outcomes

Primary

Measure	Time frame
-The presence or absence of HCV DAA-resistant amino acid mutations -The presence or absence of HCV NS3 area DAA-resistant amino acid mutations -The presence or absence of HCV NS5A area DAA-resistant amino acid mutations -The presence or absence of HCV NS5B area DAA-resistant amino acid mutations	—

Countries

Japan

Contacts

Public ContactMiuma Satoshi

Nagasaki University Hospital Gastroenterology and Hepatology

miuma1002@gmail.com095-819-7841

Outcome results